Back to articles
Jesse Landry

Audicin Raises $1.9M to Embed Real-Time Nervous System Regulation into Wearables and Apps

Funding Details

Amount

$1.9M

Round

Seed

Pressure doesn’t knock. It hums. Low, constant, and just loud enough to convince most people it’s normal. Cortisol plays background music, the nervous system stays pinned, and somehow we call that productivity. Audicin heard the noise and decided silence wasn’t the answer. Control was.

Audicin, the Finland-born neurotechnology company now operating out of Helsinki with eyes on the U.S., just pulled in $1.9M in seed funding and didn’t bother making noise about it like a rookie popping champagne. The round brings total funding to roughly $3M, backed by names that understand signal over noise, including Oura co-founders Petteri Lahtela and Virpi Tuomivaara, along with support from Business Finland’s Deep Tech Accelerator. Smart money, not loud money.

Credit where it’s due. Laura Avonius, Founder and CEO, and Dr. Victoria Williamson, Co-founder and Chief Scientist, aren’t building another wellness app that reminds you to breathe like you forgot. They’re engineering sound that nudges your nervous system out of fight-or-flight and into something that actually resembles control. Music meets neuroscience, and not in a “trust us, it feels good” way. This is built on research, tuned with intent, and deployed where stress doesn’t clock out.

The numbers don’t scream. They lean in. A sales pipeline pushing $8M across defense, performance, and wellness. User growth up 40% in 12 weeks without paid marketing. iOS revenue quietly doubling in the same window. That’s not luck. That’s product-market fit showing up uninvited and making itself comfortable.

Then you look at the pilots. Finland’s S-Group employees reporting 70% improvement in wellbeing, 20% fewer sick days, and productivity jumping 4x. Healthcare workers seeing HRV climb 22% and stress indicators drop 68% in 2 weeks. 10 minutes of listening during routine work shifting physiology. Not motivation. Physiology. That’s a different game entirely.

The product stack reads like it’s thinking ahead of the room. A mobile app that runs in the background while you work. An SDK, Audicin for Apps, sliding into wearables and partner platforms like it belongs there. A Sleep Headband built for environments where phones are locked out but stress still clocks in. Defense. Hospitals. High-performance settings where “take a break” isn’t on the menu.

Here’s the real play. Most of the market tracks stress. Charts it. Colors it red and calls it insight. Audicin treats it like a system you can actually influence in real time. Less dashboard, more intervention. Less reflection, more recalibration. And that’s the shift worth paying attention to. When recovery stops being an activity and starts becoming infrastructure, you don’t just improve performance. You redefine what baseline even means.